Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1993 Apr 15;90(8):3476–3480. doi: 10.1073/pnas.90.8.3476

Enzymatic modification of plasma low density lipoproteins in rabbits: a potential treatment for hypercholesterolemia.

R Labeque 1, C J Mullon 1, J P Ferreira 1, R S Lees 1, R Langer 1
PMCID: PMC46323  PMID: 8475095

Abstract

Phospholipase A2 (EC 3.1.1.4) hydrolyzes certain phospholipids of low density lipoprotein (LDL). Plasma clearance of phospholipase A2-modified human LDL is up to 17 times faster than that of native human LDL in hypercholesterolemic rabbits. Modification of blood lipoproteins of hypercholesterolemic rabbits was performed by using an extracorporeal circuit containing immobilized phospholipase A2. After 90-min treatments, nearly 30% decreases in plasma cholesterol concentrations were observed. Erythrocyte, leukocyte, and platelet counts showed no net change after treatment. This technique does not require any fluid replacement or sorbent regeneration and offers a potential approach for lowering serum cholesterol and LDL levels.

Full text

PDF
3476

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aggerbeck L. P., Kézdy F. J., Scanu A. M. Enzymatic probes of lipoprotein structure. Hydrolysis of human serum low density lipoprotein-2 by phospholipase A2. J Biol Chem. 1976 Jun 25;251(12):3823–3830. [PubMed] [Google Scholar]
  2. Allain C. C., Poon L. S., Chan C. S., Richmond W., Fu P. C. Enzymatic determination of total serum cholesterol. Clin Chem. 1974 Apr;20(4):470–475. [PubMed] [Google Scholar]
  3. Angelico M., Alvaro D., Masella R., Ginanni Corradini S., Cantafora A. Transport, utilization and biliary secretion of lysophosphatidylcholine in the rat liver. Biochim Biophys Acta. 1987 Nov 27;905(1):91–99. doi: 10.1016/0005-2736(87)90012-5. [DOI] [PubMed] [Google Scholar]
  4. Apstein C. S., Zilversmit D. B., Lees R. S., George P. K. Effect of intessive plasmapheresis on the plasma cholesterol concentration with familial hypercholesterolemia. Atherosclerosis. 1978 Oct;31(2):105–115. doi: 10.1016/0021-9150(78)90157-0. [DOI] [PubMed] [Google Scholar]
  5. BARTLETT G. R. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed] [Google Scholar]
  6. Bilheimer D. W., Eisenberg S., Levy R. I. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta. 1972 Feb 21;260(2):212–221. doi: 10.1016/0005-2760(72)90034-3. [DOI] [PubMed] [Google Scholar]
  7. Bilheimer D. W., Goldstein J. L., Grundy S. M., Brown M. S. Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia. J Clin Invest. 1975 Dec;56(6):1420–1430. doi: 10.1172/JCI108223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bilheimer D. W., Stone N. J., Grundy S. M. Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo. J Clin Invest. 1979 Aug;64(2):524–533. doi: 10.1172/JCI109490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Borensztajn J., Kotlar T. J. Hepatic uptake of phospholipid-depleted chylomicrons in vivo. Comparison with the uptake of chylomicron remnants. Biochem J. 1981 Dec 15;200(3):547–553. doi: 10.1042/bj2000547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Buege J. A., Aust S. D. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302–310. doi: 10.1016/s0076-6879(78)52032-6. [DOI] [PubMed] [Google Scholar]
  11. Eisenhauer T., Armstrong V. W., Wieland H., Fuchs C., Scheler F., Seidel D. Selective removal of low density lipoproteins (LDL) by precipitation at low pH: first clinical application of the HELP system. Klin Wochenschr. 1987 Feb 16;65(4):161–168. doi: 10.1007/BF01728226. [DOI] [PubMed] [Google Scholar]
  12. Goldstein J. L., Basu S. K., Brown M. S. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 1983;98:241–260. doi: 10.1016/0076-6879(83)98152-1. [DOI] [PubMed] [Google Scholar]
  13. Goldstein J. L., Brown M. S. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977;46:897–930. doi: 10.1146/annurev.bi.46.070177.004341. [DOI] [PubMed] [Google Scholar]
  14. Hachimori Y., Wells M. A., Hanahan D. J. Observations on the phospholipase A 2 of Crotalus atrox. Molecular weight and other properties. Biochemistry. 1971 Oct 26;10(22):4084–4089. doi: 10.1021/bi00798a012. [DOI] [PubMed] [Google Scholar]
  15. Hatch F. T. Practical methods for plasma lipoprotein analysis. Adv Lipid Res. 1968;6:1–68. [PubMed] [Google Scholar]
  16. Homma Y., Mikami Y., Tamachi H., Nakaya N., Nakamura H., Goto Y. Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis, and changes of subfractionated plasma lipoproteins after plasmapheresis in heterozygous familial hypercholesterolemia. Metabolism. 1987 May;36(5):419–425. doi: 10.1016/0026-0495(87)90037-0. [DOI] [PubMed] [Google Scholar]
  17. King M. E., Breslow J. L., Lees R. S. Plasma-exchange therapy of homozygous familial hypercholesterolemia. N Engl J Med. 1980 Jun 26;302(26):1457–1459. doi: 10.1056/NEJM198006263022607. [DOI] [PubMed] [Google Scholar]
  18. Kita T., Brown M. S., Watanabe Y., Goldstein J. L. Deficiency of low density lipoprotein receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2268–2272. doi: 10.1073/pnas.78.4.2268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  20. Langer R., Linhardt R. J., Hoffberg S., Larsen A. K., Cooney C. L., Tapper D., Klein M. An enzymatic system for removing heparin in extracorporeal therapy. Science. 1982 Jul 16;217(4556):261–263. doi: 10.1126/science.7089564. [DOI] [PubMed] [Google Scholar]
  21. Lavin A., Sung C., Klibanov A. M., Langer R. Enzymatic removal of bilirubin from blood: a potential treatment for neonatal jaundice. Science. 1985 Nov 1;230(4725):543–545. doi: 10.1126/science.4048947. [DOI] [PubMed] [Google Scholar]
  22. Lees R. S., Garabedian H. D., Lees A. M., Schumacher D. J., Miller A., Isaacsohn J. L., Derksen A., Strauss H. W. Technetium-99m low density lipoproteins: preparation and biodistribution. J Nucl Med. 1985 Sep;26(9):1056–1062. [PubMed] [Google Scholar]
  23. Lupien P. J., Moorjani S., Lou M., Brun D., Gagné C. Removal of cholesterol from blood by affinity binding to heparin-agarose: evaluation on treatment in homozygous familial hypercholesterolemia. Pediatr Res. 1980 Feb;14(2):113–117. doi: 10.1203/00006450-198002000-00009. [DOI] [PubMed] [Google Scholar]
  24. MATTHEWS C. M. The theory of tracer experiments with 131I-labelled plasma proteins. Phys Med Biol. 1957 Jul;2(1):36–53. doi: 10.1088/0031-9155/2/1/305. [DOI] [PubMed] [Google Scholar]
  25. Marinetti G. V. The action of phospholipase A on lipoproteins. Biochim Biophys Acta. 1965 Jun 1;98(3):554–565. doi: 10.1016/0005-2760(65)90152-9. [DOI] [PubMed] [Google Scholar]
  26. McFARLANE A. S. Efficient trace-labelling of proteins with iodine. Nature. 1958 Jul 5;182(4627):53–53. doi: 10.1038/182053a0. [DOI] [PubMed] [Google Scholar]
  27. Minick C. R., Stemerman M. G., Insull W., Jr Effect of regenerated endothelium on lipid accumulation in the arterial wall. Proc Natl Acad Sci U S A. 1977 Apr;74(4):1724–1728. doi: 10.1073/pnas.74.4.1724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Nieuwenhuizen W., Kunze H., de Haas G. H. Phospholipase A2 (phosphatide acylhydrolase, EC 3.1.1.4) from porcine pancreas. Methods Enzymol. 1974;32:147–154. doi: 10.1016/0076-6879(74)32018-6. [DOI] [PubMed] [Google Scholar]
  29. Ostlund R. E., Jr Immunosorbent chemistry: a study of agarose-based column sorbents for the removal of low-density lipoprotein (LDL) from blood. Artif Organs. 1987 Oct;11(5):366–374. doi: 10.1111/j.1525-1594.1987.tb00947.x. [DOI] [PubMed] [Google Scholar]
  30. Ostlund R. E., Jr Removal of apolipoprotein B from dog whole blood by ex vivo hemoadsorption on antibody-agarose beads. Artif Organs. 1988 Dec;12(6):491–496. doi: 10.1111/j.1525-1594.1988.tb02810.x. [DOI] [PubMed] [Google Scholar]
  31. Quinn M. T., Parthasarathy S., Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2805–2809. doi: 10.1073/pnas.85.8.2805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Saal S. D., Parker T. S., Gordon B. R., Studebaker J., Hudgins L., Ahrens E. H., Jr, Rubin A. L. Removal of low-density lipoproteins in patients by extracorporeal immunoadsorption. Am J Med. 1986 Apr;80(4):583–589. doi: 10.1016/0002-9343(86)90811-9. [DOI] [PubMed] [Google Scholar]
  33. Shih I. L., Lees R. S., Chang M. Y., Lees A. M. Focal accumulation of an apolipoprotein B-based synthetic oligopeptide in the healing rabbit arterial wall. Proc Natl Acad Sci U S A. 1990 Feb;87(4):1436–1440. doi: 10.1073/pnas.87.4.1436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Sparrow C. P., Parthasarathy S., Steinberg D. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification. J Lipid Res. 1988 Jun;29(6):745–753. [PubMed] [Google Scholar]
  35. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989 Apr 6;320(14):915–924. doi: 10.1056/NEJM198904063201407. [DOI] [PubMed] [Google Scholar]
  36. Stoffel W., Borberg H., Greve V. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia. Lancet. 1981 Nov 7;2(8254):1005–1007. doi: 10.1016/s0140-6736(81)91213-7. [DOI] [PubMed] [Google Scholar]
  37. Tanzawa K., Shimada Y., Kuroda M., Tsujita Y., Arai M., Watanabe H. WHHL-rabbit: a low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia. FEBS Lett. 1980 Aug 25;118(1):81–84. doi: 10.1016/0014-5793(80)81223-3. [DOI] [PubMed] [Google Scholar]
  38. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA. 1984 Jan 20;251(3):351–364. doi: 10.1001/jama.1984.03340270029025. [DOI] [PubMed] [Google Scholar]
  39. Turley S. D., Dietschy J. M. Re-evaluation of the 3 alpha-hydroxysteroid dehydrogenase assay for total bile acids in bile. J Lipid Res. 1978 Sep;19(7):924–928. [PubMed] [Google Scholar]
  40. Watanabe Y. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis. 1980 Jun;36(2):261–268. doi: 10.1016/0021-9150(80)90234-8. [DOI] [PubMed] [Google Scholar]
  41. Wiklund O., Witztum J. L., Carew T. E., Pittman R. C., Elam R. L., Steinberg D. Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits. J Lipid Res. 1987 Sep;28(9):1098–1109. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES